Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
News Focus
Golden Cariboo (CSE:GCC) (OTC:GCCFF) Unlocks Cariboo Gold Potential (click to learn more) An Emerging Name in Cannabis: HERB (click to learn more) AI-Driven Wellness Play on the CSE (click to learn more)
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Price History  |  Ratios  |  Insiders

Stock Quote Today & Recent News Sutro Biopharma Inc STRO

Healthcare Biotechnology
Sutro Biopharma, Inc. operates as a oncology company. The company develops site-specific and novel-format antibody drug conjugates (ADCs) that enables its proprietary integrated cell-free protein synthesis platform, XpressCF; and site-specific conjugation platform, XpressCF+. Its lead product candidate includes STRO-004, a tissue factor (TF) targeting ADC for the treatment of TF-expressing... see more
{{currentVideo.companyName}}
{{currentVideo.intervieweeName}}{{currentVideo.intervieweeTitle}}
{{currentVideo.headline}}
{{currentVideo.link1Text}}
{{currentVideo.link2Text}}
< Previous
{{moreVideoText}}
Next >

Current News (NDAQ:STRO)

Sutro Biopharma Announces Pricing of $110.0 million Underwritten Offering

GlobeNewswire 2 days ago

Sutro Biopharma to Present at the 44th Annual J.P. Morgan Healthcare Conference

GlobeNewswire January 7, 2026

Sutro Biopharma Regains Compliance with Nasdaq Minimum Bid Price Requirement

GlobeNewswire December 17, 2025

Sutro Biopharma Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

GlobeNewswire December 16, 2025

Sutro Biopharma Announces First Cohort of Patients Dosed in Phase 1 Trial of STRO-004, a Next-Generation Tissue Factor ADC, in TF-Expressing Solid Tumors

GlobeNewswire December 3, 2025

Sutro Biopharma Announces 1-for-10 Reverse Stock Split

GlobeNewswire December 1, 2025

Sutro Biopharma Highlights Next-Generation ADC Innovation at Virtual R&D Day

GlobeNewswire November 12, 2025

Sutro Biopharma Reports Third Quarter 2025 Financial Results and Business Highlights

GlobeNewswire November 6, 2025

Sutro Biopharma to Host Virtual Research & Development Day on November 12, 2025

GlobeNewswire November 5, 2025
View More News ››

Opinion & Analysis (NDAQ:STRO)

No current opinion is available.
View More Opinion ››

Bullboard Posts (NDAQ:STRO)

4 BIOTECH STOCKS THAT WARRANT YOUR ATTENTION!

$STRO $MTEM $SNDX $KRYS Clinical-Stage companies offer an exciting investment opportunity with massive upside potential. Most of...
AviseAnalytics - October 5, 2021
View more Bullboard ››

AE Fuels Corporation

AE Fuels Corporation

AE Fuels Corporation (TSXV: AEF) is a battery materials company focused on the extraction and purification of minerals ...
View More »

Podcasts